Comparative Renoprotective Effect of Febuxostat and Allopurinol in Predialysis Stage 5 Chronic Kidney Disease Patients: A Nationwide Database Analysis

Hyperuricemia has been associated with chronic kidney disease (CKD) progression. The antihyperuricemic febuxostat's potential renoprotective effect has been demonstrated in stage 1–3 CKD. Large‐scale studies comparing the renoprotective potential of febuxostat and allopurinol in advanced CKD ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Yun‐Shiuan O., Wu, I‐Wen, Chang, Shang‐Hung, Lee, Cheng‐Chia, Tsai, Chung‐Ying, Lin, Chan‐Yu, Lin, Wan‐Ting, Huang, Yu‐Tung, Wu, Chao‐Yi, Kuo, George, Hsiao, Chih‐Yen, Lin, Hsing‐Lin, Yang, Chih‐Chao, Yen, Tzung‐Hai, Chen, Yung‐Chang, Hung, Cheng‐Chieh, Tian, Ya‐Chong, Kuo, Chang‐Fu, Yang, Chih‐Wei, Anderson, Gerard F., Yang, Huang‐Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232862/
https://www.ncbi.nlm.nih.gov/pubmed/31628864
http://dx.doi.org/10.1002/cpt.1697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232862/
https://www.ncbi.nlm.nih.gov/pubmed/31628864
http://dx.doi.org/10.1002/cpt.1697

Ejemplares similares